Sarah E. Davis
Impact in
- Immunology top 10%
- Galectins and Cancer Biology
-
- Viral Infections and Immunology Research
Papers in
- Virology 5
- HIV Research and Treatment 5
-
- HIV/AIDS drug development and treatment 4
- Co-authors
- Aseem Z. Ansari (3 shared papers)Rachel Anne Mooney (2 shared papers)Robert C. Landick (2 shared papers)Sylvia Frisancho‐Kiss (2 shared papers)Noel R. Rose (2 shared papers)Jennifer F. Nyland (2 shared papers)Daniela Čiháková (2 shared papers)Masheka A. Barrett (2 shared papers)
- Journals
- Nuclear Technology (2 papers)Journal of Pharmacology and Experimental Therapeutics (2 papers)PLoS ONE (2 papers)The Journal of Immunology (2 papers)Pharmacology Research & Perspectives (1 paper)
- Partner nations
- United StatesUnited KingdomAustralia
In The Last Decade
Sarah E. Davis
27 papers receiving 884 citations
Peers
Comparison fields: 5 of 112
- Immunology 203
- Cardiology and Cardiovascular Medicine 145
- Genetics 182
- Molecular Biology 387
- Infectious Diseases 95
Countries citing papers authored by Sarah E. Davis
This map shows the geographic impact of Sarah E. Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah E. Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah E. Davis more than expected).
Fields of papers citing papers by Sarah E. Davis
This network shows the impact of papers produced by Sarah E. Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah E. Davis. The network helps show where Sarah E. Davis may publish in the future.
Co-authors
The 25 scholars most cited alongside Sarah E. Davis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 198 | |
| 2 | 2007 | 183 | |
| 3 | 2006 | 122 | |
| 4 | 2010 | 102 | |
| 5 | 2014 | 64 | |
| 6 | 2023 | 31 | |
| 7 | 2014 | 28 | |
| 8 | 2019 | 22 | |
| 9 | 2011 | 18 | |
| 10 | 2019 | 16 | |
| 11 | 2009 | 15 | |
| 12 | 2021 | 11 | |
| 13 | 2022 | 11 | |
| 14 | 2019 | 10 | |
| 15 | 2013 | 9 | |
| 16 | 2005 | 9 | |
| 17 | 2022 | 8 | |
| 18 | 2018 | 6 | |
| 19 | 2020 | 6 | |
| 20 | 2022 | 6 |
About Sarah E. Davis
Sarah E. Davis is a scholar working on Virology, Infectious Diseases, Cellular and Molecular Neuroscience, Molecular Biology and Pharmacology, having authored 28 papers that have together received 895 indexed citations. Recurring topics across this work include HIV Research and Treatment (5 papers), HIV/AIDS drug development and treatment (4 papers), Neuroscience and Neuropharmacology Research (3 papers), Fungal Infections and Studies (2 papers), Bacterial Genetics and Biotechnology (2 papers), Galectins and Cancer Biology (2 papers), Inflammatory mediators and NSAID effects (2 papers) and Receptor Mechanisms and Signaling (2 papers). The work is most often cited by research in Immunology (203 citations), Cardiology and Cardiovascular Medicine (145 citations), Genetics (182 citations), Molecular Biology (387 citations) and Infectious Diseases (95 citations). Sarah E. Davis has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Aseem Z. Ansari, Rachel Anne Mooney, Robert C. Landick, Sylvia Frisancho‐Kiss, Noel R. Rose, Jennifer F. Nyland, Daniela Čiháková, Masheka A. Barrett, DeLisa Fairweather and Jennifer L. Rowland. Their work appears in journals such as Nuclear Technology, Journal of Pharmacology and Experimental Therapeutics, PLoS ONE, The Journal of Immunology and Pharmacology Research & Perspectives.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.